Sign In
Buy PRME
$3.52
-0.265 (-7.01%)
At Close: Jul 13, 2026
Prime Medicine sets IPO terms, which could value the biotech at up to $1.7 billion
11:40am, Thursday, 13'th Oct 2022
Prime Medicine Inc. PRME, has set terms for its initial public offering, in which the Massachusetts-based biotechnology company, which utilizes gene-editing technology to develop therapies for a wide
